Health GeoVax Appoints Recognized Industry Leader John W. Sharkey, PhD as Vice President, Business Development June 13, 2022
Health Fulcrum Therapeutics Announces Proof-of-Concept for FTX-6058 in Sickle Cell Disease Based on Initial Data from the Ongoing Phase 1b Trial June 10, 2022
Health Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl) June 10, 2022
Health Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 10, 2022
Health Tonix Pharmaceuticals Announces Data Presentations Involving TNX-1500 (Fc-modified anti-CD40L mAb) for the Prevention of Rejection in Kidney and Heart Allograft Transplantation in Animal Models at the 2022 American Transplant Congress June 9, 2022
Health ISS Recommends Guardion Stockholders Vote for the Increase in Shares for Equity Plan and for the Reverse Stock Split at Guardion’s Upcoming 2022 Annual Stockholders’ Meeting June 9, 2022
Health Evoke Pharma Regains Compliance with Nasdaq Listing Requirements and Provides Financial Update June 8, 2022